Modulation of Δ9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat

British Journal of Pharmacology

Volumn 124, Issue 7, 1998, Pages 1419-1424

  Malone, Daniel T ^a   Taylor, David A ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

9 THC; 5 HT; Fluoxetine; Hypothermia; SR 141716

Indexed keywords

AUTORECEPTOR; DRONABINOL; FLUOXETINE; RIMONABANT; SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; WISTAR RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; HYPOTHERMIA; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; TETRAHYDROCANNABINOL;

EID: 0031595233     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701980     Document Type: Article

References (38)

1. ACETO, M.D., SCATES, S.M., LOWE, J.A. & MARTIN, B.R. (1995). Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR141716A. Eur. J. Pharmacol., 282, R1-R2.
2. 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol. Rev., 38, 21-43.
3. 1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 157-165.
4. ARTIGAS, F. (1993). 5-HT and antidepressants: new views from microdialysis studies Trends. Pharmacol. Sci., 14, 262.
5. BAGDY, G. & TO, C.T. (1997). Comparison of relative potenticies of i.v. and i.c.v. administered 8-OH-DPAT gives evidence of different sites of action for hypothermia, lower lip retraction and tail flicks. Eur. J. Pharmacol., 323, 53-58.
6. BARG, J., FRIDE, E., HANUS, L., LEVY, R., MATUS-LEIBOVITCH, N., HELDMAN, E., MAYEWITCH, M., MECHOULAM, R. & VOGEL, Z., (1995). Cannabinomimetic behavioural effects of and adenylate cyclase inhibition by two new endogenous ananadamides. Eur. J. Pharmacol., 287, 145-152.
7. 1Areceptor agonist properties. Eur. J. Pharmacol., 322, 147-153.
8. BIEGON, A., SEGAL, M. & SAMUEL, D. (1979). Sex differences in behavioural and thermal responses to pargyline and tryptophan. Psychopharmacol., 61, 77-80.
9. CHAPUT, Y., DE MONTIGNY, C. & BLIER, P. (1986). Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 333, 342-348.
10. COMPTON, DR., ACETO, M.D., LOWE, J. & MARTIN, B.R (1996). In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther., 277, 586-594.
11. COMPTON, D.R., JOHNSON, M.R., MELVIN, L.S. & MARTIN, B.R (1992). Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J. Pharmacol. Exp. Ther., 260, 201-209.
12. 9-tetrahydrocannabinol on body temperature in mice. Psychopharmacol., 69, 299-305.
13. DEADWYLER, S.A., HAMPSON, RE., MU, J., WHYTE, A. & CHILDERS, S. (1995). Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther., 273, 734-743.
14. FELDBERG, W. & LOTTI, V.J. (1967). Temperature responses to monoamines and an inhibitor of MAO injected into the cerebral ventricles of rats. Br. J. Pharmacol., 31, 152-161.
15. FELDBERG, W. & MYERS, R.D. (1964). Effects on temperature of amines injected into the cerebral ventricles. A new concept of temperature regulation. J. Physiol. Lond., 173, 226-237.
16. 9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at different ambient temperatures. Br. J. Pharmacol., 60, 65-71.
17. 9-tetrahydrocannabinol by clomipramine in the rat. Br. J. Pharmacol., 63, 261-273.
18. 9-tetrahydrocannabinol. Br. J. Pharmacol., 75, 409-414.
19. GALLAGER, D.W. & AGHAJANIAN, G.K. (1976). Effect of antipsychotic drugs on the firing of dorsal raphae cells. II. Reversal by picrotoxin. Eur. J. Pharmacol., 39, 357-364.
20. 1Areceptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 1064-1070.
21. GIFFORD, A.N. & ASHBY, C.R. (1996). Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist SR 141716A. J. Pharmacol. Exp. Ther., 277, 1431-1436.
22. HARDMAN, H.F., DOMINO, E.F. & SEEVERS, M.H. (1971). General pharmacological actions of some synthetic tetrahydrocannabinol derivatives. Pharmaco. Rev., 23, 295-315.
23. HERKENHAM, M., LYNN, A.B., LITTLE, M.D., JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, K.C. (1990). Cannahinoid receptor localization in brain. Proc. Natl. Acad. Sci., 87, 1932-1936.
24. 9-tetrahydrocannabinol: neurochemical and behavioural effects in the mouse. Science, 163, 1464-1467.
25. HOWLETT, A.C. & FLEMING R.M. (1984). Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol., 26, 532-538.
26. 1 receptors on peripheral nerves. Br. J. Pharmacol., 118, 2023-2028.
27. KUSTER, J.E., STEVENSON, J.I., WARD, S.J., D'AMBRA, T.E. & HAYCOCK, D.A. (1993). Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther., 264, 1352-1363.
28. LICHTMAN, A.H., COOK, S.A. & MARTIN, B.R. (1996). Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J. Pharmacol. Exp. Ther., 276, 585-593.
29. 2-noradrenergic mechanism. Brain Res., 559, 309-314.
30. MAJ, J. & MORYL, E. (1993). Effects of fluoxetine given chronically on the responsivcness of 5-HT receptor subpopulations to their agonists. Eur. J. Neuropsychopharmacol., 3, 85-94.
31. 9-THC-induced hypothermia in the rat. Proc. Aust. Soc. Clin. ExP. Pharmacol. Toxicol., 4, 122.
32. MANEUF, Y.P. & BROTCHIE, M. (1997). Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br. J. Pharmacol., 120, 1397-1398.
33. NISHIKAWA, T. & SCATTON, B. (1983). Evidence for a GABAergic inhibitory influence on serotonergic neurones originating from the dorsal raphae. Brain Res., 279, 325-329.
34. PATEL, S. & HUTSON, P.H. (1996). Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse. Eur. J. Pharmacol., 317, 197-204.
35. 1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br. J. Pharmacol., 121, 941-946.
36. SINGEWALD, N., GUO, L. & PHILIPPU, A. (1993). Release of endogenous GABA in the posterior hypothalamus of the conscious rat; effects of drugs and experimentally induced blood pressure changes. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 402-406.
37. TAPPAZ, M.L., BROWNSTEIN, M.J. & KOPPIN, I.J. (1997). Glutamate decarboxylase (GAD) and γ-aminobutryric acid (GABA) in discrete nuclei of hypothalamus and substantia nigra. Brain Res., 125, 109-121.
38. B receptors in midbrain raphe nuclei and forebrain of rats. Br. J. Pharmacol., 119, 1375-1384.